Harrow Financial Statements From 2010 to 2024

HROWM Stock   26.35  0.14  0.53%   
Harrow Health, financial statements provide useful quarterly and yearly information to potential Harrow Health, 11875 investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Harrow Health, financial statements helps investors assess Harrow Health,'s valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Harrow Health,'s valuation are summarized below:
There are over eighty-nine available fundamental trends for Harrow Health, 11875, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to confirm Harrow Health,'s regular fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 22nd of November 2024, Market Cap is likely to grow to about 883.6 M. Also, Enterprise Value is likely to grow to about 1 B
Check Harrow Health, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harrow Health,'s main balance sheet or income statement drivers, such as , as well as many indicators such as Price To Sales Ratio of 6.14, Dividend Yield of 2.0E-4 or PTB Ratio of 19.83. Harrow financial statements analysis is a perfect complement when working with Harrow Health, Valuation or Volatility modules.
  
Check out the analysis of Harrow Health, Correlation against competitors.

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.146.46365.7 K
Slightly volatile
Dividend Yield2.0E-42.0E-42.0E-4
Slightly volatile
Days Sales Outstanding10710233.7686
Slightly volatile
Stock Based Compensation To Revenue0.110.120683.7854
Slightly volatile
Capex To Depreciation0.08440.08882.3901
Slightly volatile
EV To Sales6.997.35785.3 K
Slightly volatile
Inventory Turnover5.233.64774.2996
Slightly volatile
Days Of Inventory On Hand92.8210095.6551
Slightly volatile
Payables Turnover2.241.85032.389
Slightly volatile
Sales General And Administrative To Revenue0.920.97158
Slightly volatile
Research And Ddevelopement To Revenue0.04850.051143.1383
Slightly volatile
Capex To Revenue0.01070.01120.6079
Slightly volatile
Cash Per Share2.722.59131.5995
Slightly volatile
Days Payables Outstanding170197181
Slightly volatile
Intangibles To Total Assets0.550.52080.1918
Slightly volatile
Current Ratio2.682.81848.9428
Slightly volatile
Receivables Turnover3.393.56815.9407
Slightly volatile
Graham Number3.666.04443.8636
Slightly volatile
Capex Per Share0.04250.04480.1331
Slightly volatile
Revenue Per Share4.193.99161.601
Slightly volatile
Interest Debt Per Share6.586.26972.0009
Slightly volatile
Debt To Assets0.390.58760.5225
Pretty Stable
Operating Cycle212202130
Pretty Stable
Days Of Payables Outstanding170197181
Slightly volatile
Long Term Debt To Capitalization0.730.72130.8428
Slightly volatile
Total Debt To Capitalization0.750.72130.8576
Slightly volatile
Quick Ratio2.472.59828.7373
Slightly volatile
Cash Ratio1.431.50147.8
Slightly volatile
Days Of Inventory Outstanding92.8210095.6551
Slightly volatile
Days Of Sales Outstanding10710233.7686
Slightly volatile
Fixed Asset Turnover13.2612.63274.9176
Slightly volatile
Debt Ratio0.390.58760.5225
Pretty Stable
Price Sales Ratio6.146.46365.7 K
Slightly volatile
Asset Turnover0.50.41760.4983
Slightly volatile
Gross Profit Margin0.470.69550.5186
Slightly volatile

Harrow Health, Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap883.6 M841.5 M467.5 M
Slightly volatile
Enterprise ValueB957.9 M486.5 M
Slightly volatile

Harrow Fundamental Market Drivers

Shares Short Prior Month1620

About Harrow Health, Financial Statements

Harrow Health, investors utilize fundamental indicators, such as revenue or net income, to predict how Harrow Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Stock Based Compensation To Revenue 0.12  0.11 
Sales General And Administrative To Revenue 0.97  0.92 
Research And Ddevelopement To Revenue 0.05  0.05 
Capex To Revenue 0.01  0.01 
Revenue Per Share 3.99  4.19 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Harrow Health, 11875 is a strong investment it is important to analyze Harrow Health,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health,'s future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports:
Check out the analysis of Harrow Health, Correlation against competitors.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health,. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Harrow Health, 11875 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health,'s value that differs from its market value or its book value, called intrinsic value, which is Harrow Health,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health,'s market value can be influenced by many factors that don't directly affect Harrow Health,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.